Real-time enrollment status for this acute myeloid leukemia, in relapse clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:15 PM UTC
| NCT Number | NCT04716452 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia, in Relapse |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Keystone Nano, Inc |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of July 13, 2026: Clinical trial NCT04716452 is currently recruiting participants. This clinical trial study for acute myeloid leukemia, in relapse is actively seeking new participants at 1 location across the United States. The study is sponsored by Keystone Nano, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04716452 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04716452 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.